Rein Therapeutics logo

Rein Therapeutics Share Price Today

(NASDAQ: RNTX)

Rein Therapeutics share price is $2.04 & ₹177.42 as on 6 Mar 2025, 2.30 'hrs' IST

$2.04

0.01

(0.49%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Rein Therapeutics share price in Dollar and Rupees. Guide to invest in Rein Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Rein Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Rein Therapeutics share price movements

  • Today's Low: $1.99
    Today's High: $2.23

    Day's Volatility :10.76%

  • 52 Weeks Low: $1.84
    52 Weeks High: $3.50

    52 Weeks Volatility :47.44%

Rein Therapeutics (RNTX) Returns

PeriodRein Therapeutics IncIndex (Russel 2000)
3 Months
-12.5%
0.0%
6 Months
-29.76%
0.0%
1 Year
-63.02%
0.0%
3 Years
-74.63%
-11.6%

Rein Therapeutics (RNTX) Key Statistics

in dollars & INR

Previous Close
$2.03
Open
$2.01
Today's High
$2.23
Today's Low
$1.99
Market Capitalization
$52.9M
Today's Volume
$2.8K
52 Week High
$3.5
52 Week Low
$1.8396
Revenue TTM
$0.0
EBITDA
$-29.5M
Earnings Per Share (EPS)
$-2.88
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-54.95%

How to invest in Rein Therapeutics Stock (RNTX) from India?

It is very easy for Indian residents to invest directly in Rein Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Rein Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Rein Therapeutics or RNTX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Rein Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Rein Therapeutics shares which would translate to 0.426 fractional shares of Rein Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Rein Therapeutics, in just a few clicks!

Returns in Rein Therapeutics (RNTX) for Indian investors in Rupees

The Rein Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Rein Therapeutics investment value today

Current value as on today

₹42,121

Returns

₹57,879

(-57.88%)

Returns from Rein Therapeutics Stock

₹62,842 (-62.84%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Rein Therapeutics (RNTX)

-75%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Rein Therapeutics Stock from India on INDmoney has decreased by -75% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Rein Therapeutics

Analyst Forecast on Rein Therapeutics Stock (RNTX)

What analysts predicted

Upside of 537.25%

Target:

$13.00

Current:

$2.04

Insights on Rein Therapeutics Stock (Ticker Symbol: RNTX)

  • Price Movement

    In the last 6 months, RNTX stock has moved down by -29.8%
  • RNTX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 125.7%
  • RNTX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 123.9%

Rein Therapeutics Technicals Summary

Sell

Neutral

Buy

Rein Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Rein Therapeutics (RNTX) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Rein Therapeutics Inc logo
-7.31%
-29.76%
-63.02%
-74.63%
-79.45%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Rein Therapeutics Inc logo
NA
NA
NA
-2.24
-0.55
-0.32
NA
2.32
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Rein Therapeutics Inc logo
NA
$52.9M
-79.45%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Rein Therapeutics

Rein Therapeutics Inc., a biopharmaceutical company, focuses on developing medicines to address unmet medical needs in orphan pulmonary and fibrosis indications in the United States. The company's lead product candidate is LTI-03, a peptide, which is in Phase 1b clinical trial for the treatment of idiopathic pulmonary fibrosis (IPF). Its second product candidate is LTI-01, a proenzyme that has completed Phase 1b and Phase 2a clinical trials in LPE patients for the treatment of loculated pleural effusion. The company's pipeline also includes preclinical programs targeting cystic fibrosis and a peptide program focused on the caveolin-1 protein for systemic fibrosis indications. The company was formerly known as Aileron Therapeutics, Inc. and changed its name to Rein Therapeutics Inc. in February 2007. Rein Therapeutics Inc. was incorporated in 2001 and is headquartered in Austin, Texas.
Organization
Rein Therapeutics
Employees
15
CEO
Dr. James Brian Windsor Ph.D.
Industry
Miscellaneous

Management People of Rein Therapeutics

NameTitle
Dr. James Brian Windsor Ph.D.
CEO, President & Director
Mr. Timothy M. Cunningham CPA, M.B.A.
Interim CFO & Principal Accounting Officer
Dr. Cory M. Hogaboam Ph.D.
Chief Scientific Officer

Important FAQs about investing in RNTX Stock from India :

What is Rein Therapeutics share price today?

Rein Therapeutics share price today stands at $2.04, Open: $2.01 ; Previous Close: $2.03 ; High: $2.23 ; Low: $1.99 ; 52 Week High: $3.50 ; 52 Week Low: $1.84.

The stock opens at $2.01, after a previous close of $2.03. The stock reached a daily high of $2.23 and a low of $1.99, with a 52-week high of $3.50 and a 52-week low of $1.84.

Can Indians buy Rein Therapeutics shares?

Yes, Indians can invest in the Rein Therapeutics (RNTX) from India.

With INDmoney, you can buy Rein Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Rein Therapeutics at zero transaction cost.

How can I buy Rein Therapeutics shares from India?

It is very easy to buy Rein Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Rein Therapeutics (RNTX) be purchased?

Yes, you can buy fractional shares of Rein Therapeutics with INDmoney app.

What are the documents required to start investing in Rein Therapeutics stocks?

To start investing in Rein Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Rein Therapeutics Stock (RNTX)?

Today’s highest price of Rein Therapeutics (RNTX) is $2.23.

Today’s lowest price of Rein Therapeutics (RNTX) is $1.99.

What is today's market capitalisation of Rein Therapeutics?

Today's market capitalisation of Rein Therapeutics RNTX is 52.9M

What is the 52 Week High and Low Range of Rein Therapeutics Stock (RNTX)?

  • 52 Week High

    $3.50

  • 52 Week Low

    $1.84

What are the historical returns of Rein Therapeutics (RNTX)?

  • 1 Month Returns

    -7.31%

  • 3 Months Returns

    -29.76%

  • 1 Year Returns

    -63.02%

  • 5 Years Returns

    -79.45%

Who is the Chief Executive Officer (CEO) of Rein Therapeutics ?

Dr. James Brian Windsor Ph.D. is the current Chief Executive Officer (CEO) of Rein Therapeutics.